Y-MABS THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.74 USD | -3.73% |
|
-31.96% | +71.70% |
| May. 08 | Transcript : Y-mAbs Therapeutics, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
| May. 07 | Earnings Flash (YMAB) Y-MABS THERAPEUTICS Posts Q1 Revenue $19.9M, vs. Street Est of $22.2M | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Y-MABS THERAPEUTICS, INC. | Bio Therapeutic Drugs | -3.94% | -31.96% | +71.70% | +13.91% | -44.24% | 535M |  |  | |
Technical Rankings Surperformance
- Stock Market
- Equities
- YMAB Stock
- Charts Y-mAbs Therapeutics, Inc.
- Comparison Chart